Previous close | 3.0000 |
Open | 3.0000 |
Bid | 0.0000 |
Ask | 0.0000 |
Strike | 75.00 |
Expiry date | 2024-01-19 |
Day's range | 3.0000 - 3.0000 |
Contract range | N/A |
Volume | |
Open interest | 985 |
Amgen (AMGN) beats Q4 estimates for earnings and sales. It launches Amjevita in the United States, which is the first biosimilar of Humira to be launched in the country.
The FTSE 100 index had a good January, rising by 4.3%. While the shares of 86 Footsie firms rose last month, these three stocks slumped. The post These were the FTSE 100’s biggest flops in January! appeared first on The Motley Fool UK.
Top dividend stocks are capable of delivering above-average returns returns in any type of market. Which dividend stocks are no-brainer buys for retail investors right now? AstraZeneca (NASDAQ: AZN), Merck (NYSE: MRK), and Medtronic (NYSE: MDT) are three elite income stocks that have recession-proof businesses, strong growth prospects, and ample free cash flows.